Skip to main content
. 2020 Nov 1;23(11):e25637. doi: 10.1002/jia2.25637

Table 4.

Barriers to obtain ART and strategies to solve ATI among PLHIV at risk of ATI during the COVID‐19 outbreak in China

Characteristics

Total (N = 1782)

N (%)

Threatened but resolved risk of ATI (N = 730)

n (%)

Risk of imminent ATI

(N = 917)

n (%)

Experienced ATI (N = 135)

n (%)

No. days of ART reserve when PLHIV realized risk of ATI: Median (IQR) 10 (6 to 15) 10 (6 to 20) 10 (7 to 15)a 5 (0 to 14)b
Strategies used to solve ATI
Disclosed HIV status and applied for permission to travel to an HIV clinic 87 (4.88) 42 (5.75) 42 (4.58) 3 (2.22)
Pretended to have a disease other than HIV requiring urgent care 862 (48.37) 436 (59.73) 374 (40.79) 52 (38.52)
Decided not to obtain ART to avoid disclosure of HIV status 637 (35.75) 80 (10.96) 502 (54.74) 55 (40.74)
Otherc 361 (20.26) 199 (27.26) 136 (14.83) 26 (19.26)
Barriers to obtaining ART from HIV clinics during COVID‐19
Cumbersome administrative procedures 911 (51.12) 379 (51.92) 463 (50.49) 69 (51.11)
Lockdown and travel restrictions 1172 (65.77) 449 (61.51) 627 (68.38) 96 (71.11)
Fear of disclosing HIV status 1379 (77.38) 584 (80.00) 696 (75.90) 99 (73.33)
Otherd 192 (10.77) 90 (12.33) 86 (9.38) 16 (11.85)
Preferred way of obtaining additional ART during COVID‐19
Mailed by one’s primary HIV clinic 1418 (79.57) 580 (79.45) 731 (79.72) 107 (79.26)
Dispensed by a nearby HIV clinic other than one’s primary HIV clinic 251 (14.09) 100 (13.70) 128 (13.96) 23 (17.04)
Purchased online and delivered by mail 113 (6.34) 50 (6.85) 58 (6.32) 5 (3.70)

ART, antiretroviral therapy; ATI, antiretroviral therapy interruption; IQR, interquartile range; PLHIV, people living with HIV.

a

1 missing

b

1 missing

c

other includes violating travel restrictions to reach an HIV clinic and purchasing ART out of pocket

d

other includes insufficient ART supply at local clinics, suspension of postal and courier services and no response from local clinics.